Article

cambridgeindependent.co.ukcambridgeindependent.co.uk on 2020-07-28 11:29

AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

The deal surrounds antibody drug conjugate DS-1062, which could redefine treatments in lung, breast and multiple other cancers.

Related news